Technology funder adds further investment to growing biotech

Mark Payton, CEO of Mercia Technologies
Specialist funder Mercia Technologies is investing a further £500,000 into one of its portfolio companies. The Warwickshire-based investor, which specialises in funding and scaling innovative technology businesses with high growth potential, is ploughing the money into Oxford Genetics, a synthetic biology company with significant expertise in DNA design. The investment follows the £1m of additional capital injected by Mercia into the business last October ito enable it to expand its management team, board, patent portfolio and... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
Close